Multivariate analysis of risk factors for cisplatin-induced nephrotoxicity in gynecological cancer
Author:
Affiliation:
1. Department of Pharmacy; Aichi Medical University School of Medicine; Aichi Japan
2. Department of Obstetrics and Gynecology; Aichi Medical University School of Medicine; Aichi Japan
Publisher
Wiley
Subject
Obstetrics and Gynecology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jog.13457/fullpdf
Reference12 articles.
1. Clinical development of platinum complexes in cancer therapy: An historical perspective and an update;Lebwohl;Eur J Cancer,1998
2. Weekly high-dose cisplatin is a feasible treatment option: Analysis on prognostic factors for toxicity in 400 patients;Jongh;Br J Cancer,2003
3. Improvement of cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model;Cvitkovie;Cancer,1977
4. Combination chemotherapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck;Wittes;Oncology,1975
5. Mechanisms of cisplatin nephrotoxicity;Miller;Toxins,2010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022;International Journal of Clinical Oncology;2023-06-29
2. Assessment of cisplatin-induced nephrotoxicity and its associated factors among cervical cancer patients in the leading tertiary hospital in Kenya;Journal of Oncology Pharmacy Practice;2022-08-05
3. Renal function impairment in cervical cancer patients treated with cisplatin-based chemoradiation: A review of medical records in a Zimbabwean outpatient department;PLOS ONE;2021-02-24
4. Comparison of Equations To Estimate Glomerular Filtration Rate and Their Impact on Frequency of Cisplatin-associated Acute Kidney Injury;Kidney360;2020-12-29
5. Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients;Frontiers in Pharmacology;2020-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3